Management of severe theophylline overdosage by charcoal haemoperfusion. by Uprichard, A. C. et al.
Case Report:
MANAGEMENT OF SEVERE THEOPHYLLINE OVERDOSAGE
BY CHARCOAL HAEMOPERFUSION
by
A. C. UPRICHARD,1 R. BAILIE2 and E. McATEER3
Royal Victoria Hospital, Belfast
XANTHINE derivatives are widely used in the treatment of asthma and related
conditions and are increasingly implicated in cases of attempted suicide by
overdosage. We report the case of a potentially lethal overdose of a long-acting
theophylline preparation successfully treated by charcoal haemoperfusion.
A 28-year-old unemployed bar manager presented to the Casualty Department at
4.00 am having consumed fifty 400 mg tablets of a slow-release preparation of
theophylline ("Uniphylline" Napp Laboratories) three hours previously. An
asthmatic since childhood, he had been taking 400 mg of this preparation daily for
the previous year. There was no past psychiatric history and the taking of the
overdose of tablets appeared to be a reactionary gesture following a disagreement
with a close friend.
He was fully alert and orientated although nauseated and retching. His pulse was
regular (160 per minute), blood pressure 120/70 mmHg. He was not dehydrated and
showed no cerebral irritability. ECG showed sinus tachycardia with no other
disturbance of rhythm. The stomach was washed out. He was transferred to the
Coronary Care Unit for cardiac monitoring. The initial serum theophylline level was
greater than 80 mg/L (60 mg/L is accepted as representing severe poisoning'). Two
hours later this had fallen slightly and it was decided to continue conservative
management, but later that morning he developed signs of increasing toxicity with a
tachycardia of 200 per minute, and his blood pressure fell to 90/60 mmHg. Five
hours after admission, serum theophylline was greater than 120 mg/L and the
patient was transferred to the Intensive Care Unit for charcoal haemoperfusion.
Femoral arterial and venous cannulae were inserted and he was started on
haemoperfusion through a standard adult- haemoperfusion column. He was
intubated andventilated fortheduration oftheprocedure. Constant haemoperfusion
was continued for nine hours. During haemoperfusion his platelet count fell to
65,000/uml and he required a transfusion of platelets from six donors. Two short
runs of self-terminating ventricular tachycardia occurred early on in the procedure,
but otherwise he remained in sinus rhythm throughout. Acid-base and electrolyte
status remained normal during this time.
The following morning (24 hours after admission) his theophylline level was
within the therapeutic range and he was transferred to a general medical ward and
discharged (after phychiatric assessment) three days later.
159
I Neurology Registrar, Ward 21. 2 Senior House Officer, Department.of Anaesthetics.
3 Consultant Anaesthetist, Respiratory and Intensive Care Unit.Theophylline
Theophylline is a xanthine derivative (1, 3 dimethylxanthine) from which a
number of long-acting preparations have been derived. Its prime use is in the
treatmentofasthma and chronic obstructive airwaysdisease, butitspharmacological
effects involve a number of other systems of which the cardiac and cerebral are the
most important. Even in therapeutic dosage, theophylline toxicity is a relatively
common problem although a well-defined plasma level (10-20 mg/L) has been
established.2 The most prominent symptoms of early toxicity are anorexia, nausea,
vomiting, insomnia, restlessness and irritability. Signs of severe toxicity include
delirium, tachycardia, dehydration, convulsions and coma. Hypotension is a grave
prognostic sign.
The treatment of theophylline overdosage has classically been with stomach
washout up to four hours after the overdose and with symptomatic management of
arrhythmias and convulsions. Haemodialysis or peritoneal dialysis have little
to offer, but the introduction of charcoal column haemoperfusion represents a
significant advance, and with its use there have been reports of patients surviving
with initial levels as high as 190 mg/L.3
Charcoal Haemoperfusion
Although haemoperfusion was described asameasure ofdealingwith theophylline
overdose as early as 1979,4 our patient was the first treated by this method in
Northern Ireland. Two previous patients referred to this hospital with serum levels
of greater than 60 mg/L died from extreme hypotension. We currently use an
arterio-venous pump system. After cannulation of the femoral artery and vein,
systemic arterial pressure is used to drive blood through the charcoal column, where
theophylline adsorption takes place, and the blood is then returned to the patient.
Local heparinisation of the column is used to prevent clotting, and is monitored by
frequent measurement of activated clotting time. For successful haemoperfusion, a
systolic blood pressure of 100 mmHg is required, and this may need tobe maintained
with volume loading and inotropes. We hope in the near future to change to a
synchronised venous pump system which will avoid the need for arterial cannulation
and allow haemoperfusion of more hypotensive patients.
A recognised complication of the technique is a fall in the circulating platelet
count, which we measure two-hourly during perfusion. A number of explanations
have been offered for the thrombo-cytopenia, the most likely being that platelets
adhere to the column. This is often a transitory phenomenon, but it is not unusual
for platelet transfusion to be required.
COMMENTS
The purpose of presenting this case is to make two points. Firstly, we wish to
emphasise the importance ofrepeated serum theophylline levels during the manage-
ment of theophylline overdosage. Clinical features do not correlate well with the
plasma levels and early signs of toxicity may not always be present.5 The graph
shows a biphasic pattern in that the initial fall in theophylline levels was followed by
a sudden and potentially lethal rise. This may be due in part to the sustained release
of the theophylline preparation, although a delayed secondary rise in theophylline
concentration with recurrence of the features of toxicity has been ascribed to
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Secondly, the Royal Victoria Hospital Intensive Care Unit would wish physicians
throughout the province to be aware of the service now offered for serious over-
dosages with theophylline levels greater than 60 mg/L. As charcoal haemoperfusion
is, at present, technically impossible in the hypotensive patient, we would advocate
early referral in all such cases.
Our thanks go to the Biochemistry Department, Royal Victoria Hospital, for their help in supplying
quick and accurate theophylline levels throughout the night while our patient was being haemoperfused.
Our thanks also to Dr. J. A. Weaver for his assistance and to Miss M. Hazlett and Mrs. M. Loughran for
typing the manuscript.
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